If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRuffer Investment Company Regulatory News (RICA)

Share Price Information for Ruffer Investment Company (RICA)

Share Price is delayed by 15 minutes
Get Live Data
292.50    0.00 (0.00%)
Bid:
292.00
Ask:
294.50
Spread: 2.50 (0.856%)
Market Cap: £862.77m
RICA Live PriceLast checked at - London Stock Exchange

Intraday Ruffer Investment Company Share Chart

Interim Financial Report

18 Mar 2026 07:00

RNS Number : 0385X
Ruffer Investment Company Limited
18 March 2026
 

18 March 2026

 

RUFFER INVESTMENT COMPANY LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 41996)

(the "Company")

 

Interim Financial Report

The Company has today, in accordance with DTR 6.3.5, released its Interim Financial Report for the six months ended 31 December 2025 and a copy is attached.

http://www.rns-pdf.londonstockexchange.com/rns/0385X_1-2026-3-17.pdf

The Interim Financial Report is also available via the Investment Manager's website at www.ruffer.co.uk/2025-ric-interim-report.

A copy of the Interim Report has been submitted to the National Storage Mechanism and will shortly be available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Summary

NAV TR over the six months to 31 December 2025 was 4.9%.

The discount of the share price to NAV marginally widened to 3.6% at 31 December 2025 (from 3.4% at 30 June 2025), resulting in a slightly lower Share Price TR of 4.7% over the same period.

The NAV TR and Share Price TR for the twelve months to 31 December 2025 were 10.9% and 12.1% respectively.

The Company's investment performance has therefore met the Company's aim to generate consistent positive returns, however financial markets are performing. Additionally, returns over six and 12 months exceeded the Company's objective of twice the Bank of England base rate.

The Company has declared an interim dividend of 2.85p for the six months to 31 December 2025 (2.85p in 2024/2025).

A key action was the continuation of the Company's significant share buyback programme, which saw 2.2% of the shares outstanding at the end of the last financial year repurchased over the six-month period. Since the first share repurchase in August 2023, the Company has bought back 23.0% of its issued share capital, including 9.8% in the 2025 calendar year. The buyback is a continuing benefit for shareholders, enhancing NAV per share by 0.5% in 2025.

Financial Highlights

31 Dec 25

30 Jun 25

Share price

294.00p

284.00p

NAV as calculated on an IFRS basis1

£900.61m

£888.20m

NAV as reported to the LSE

£900.29m

£891.59m

Market capitalisation

£868.50m

£858.18m

Number of shares in issue

295,407,050

302,177,764

NAV per share as calculated on an IFRS basis1

304.87p

293.93p

NAV per share as reported to the LSE

304.76p

295.06p

 

Key Performance Indicators

31 Dec 25 %

31 Dec 24 %

Share price total return over six months

4.7

0.2

NAV total return per share over six months1,2

4.9

(0.4)

Discount of traded share price to NAV1

(3.6)

(4.5)

Dividend per share over six months3

3.35p

3.10p

Annualised dividend yield4

2.3

2.3

Annualised NAV total return per share since launch2

6.9

6.7

Ongoing charges ratio

1.08

1.08

1 This is the NAV/NAV per share (on an IFRS basis) as per the Company's Financial Statements for the six months ended 31 December 2025.

2 Assumes reinvestment of dividends.

3 Dividend declared during the period.

4 Annualised dividend yield is calculated using share price at the period end and dividends declared during the period.

Investment Performance and Outlook

RICL's positive performance in the six months to 31 December 2025 exemplifies Ruffer's ability to deliver positive returns in benign markets whilst maintaining protection to preserve capital in the event of volatility. The principal contributors to returns in the period were gold and precious metals exposure (+4.0%) and global equities (+3.5%), more than offsetting the continuing cost of protection strategies including credit and derivatives (-2.4%) and the yen (-0.9%).

The Investment Manager's report (as of 31 December 2025, and as announced by the Company by way of RNS on 27 January 2026)) highlights that the structural shifts examined in the Company's last full-year report have become realities shaping markets today. The disinflationary era underpinned by globalisation and geopolitical stability, alongside cheap labour, energy and capital, continues to unwind. Fragmentation has accelerated, with the US and China now openly competing to carve out spheres of influence and to control critical technologies and resources. Recent events are a timely reminder that this fragmentation is happening in front of investors' eyes and can flare into real-world disruption at any time.

Against this backdrop, the portfolio is positioned to reflect a variety of potential market outcomes, in line with the Company's all-weather approach. It maintains its defensive spine, made up of credit and derivative strategies, the yen and dry powder in the form of short-dated bonds and cash. At the same time, the Investment Manager has looked to reinforce the Company's exposure to attractively priced growth opportunities should risk appetite be sustained. In combination, this should allow the portfolio to prosper regardless of whether 2026 brings another year of steady ascent, a moment of overheating or renewed weakness.

The Board carefully evaluates the performance of the Investment Manager over various time periods. Ruffer's performance has now exceeded the Company's objective over one year, 10 years and 20 years. Recent performance is therefore steadily clawing back the weaker three- and five-year figures. Over the entire 21 years since inception to 31 December 2025, the Company has delivered an annualised NAV TR per share of 6.9%, exceeding the objective of twice the Bank of England base rate, which was 4.0% for the period.

The Company owns diverse growth assets, predominantly outside the US, for a scenario of benign reflation or resurgent inflation. It also retains significant protection against a sell-off if there were to be a growth slowdown or deflation. Current geopolitical tension or their resolution could impact the fragile balance between these outcomes. Consequently, the Board remains confident that RICL has an important role to play in investors' portfolios during these uncertain times.

 

Enquiries:

 

Apex Fund and Corporate Services (Guernsey) Limited

Company Secretary

James Taylor

DDI: +44 (0) 20 3530 3600

Email: RufferCoSec@apexgroup.com

 

 

LEI 21380068AHZKY7MKNO47

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FFFEFVSIDLIR
Date   Source Headline
29th Nov 20233:30 pmRNSNet Asset Value(s)
22nd Nov 202312:13 pmRNSNet Asset Value(s)
15th Nov 20232:59 pmRNSNet Asset Value(s)
14th Nov 20237:00 amRNSMonthly Investment Report - October 2023
8th Nov 20232:03 pmRNSNet Asset Value(s)
1st Nov 20231:17 pmRNSNet Asset Value(s)
27th Oct 20234:00 pmRNSNotice of AGM
25th Oct 20231:33 pmRNSNet Asset Value(s)
18th Oct 202312:47 pmRNSNet Asset Value(s)
11th Oct 20233:04 pmRNSNet Asset Value(s)
6th Oct 20233:48 pmRNSMonthly Investment Report - September 2023
4th Oct 202312:58 pmRNSNet Asset Value(s)
4th Oct 20237:00 amRNSAnnual Financial Report
3rd Oct 20234:35 pmRNSDividend Declaration
2nd Oct 20235:27 pmRNSNet Asset Value(s)
27th Sep 20231:10 pmRNSNet Asset Value(s)
20th Sep 202312:32 pmRNSNet Asset Value(s)
13th Sep 20234:45 pmRNSBlock listing Interim Review
13th Sep 20232:34 pmRNSNet Asset Value(s)
11th Sep 20237:00 amRNSMonthly Investment Report - August 2023
1st Sep 202312:27 pmRNSNet Asset Value(s)
31st Aug 20234:30 pmRNSTotal Voting Rights
30th Aug 202311:11 amRNSNet Asset Value(s)
23rd Aug 20231:00 pmRNSNet Asset Value(s)
23rd Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20233:30 pmRNSNet Asset Value(s)
10th Aug 20237:00 amRNSMonthly Investment Report - July 2023
9th Aug 20233:05 pmRNSNet Asset Value(s)
2nd Aug 20232:51 pmRNSNet Asset Value(s)
1st Aug 20233:49 pmRNSNet Asset Value(s)
26th Jul 20232:02 pmRNSNet Asset Value(s)
19th Jul 20232:48 pmRNSNet Asset Value(s)
17th Jul 20237:00 amRNSInvestment Manager's Year End Review
12th Jul 20231:17 pmRNSNet Asset Value(s)
10th Jul 20237:00 amRNSMonthly Investment Report - June 2023
7th Jul 202311:56 amRNSFund Manager Share Purchase
5th Jul 20231:48 pmRNSNet Asset Value(s)
3rd Jul 20233:13 pmRNSNet Asset Value(s)
28th Jun 20233:19 pmRNSNet Asset Value(s)
22nd Jun 20237:00 amRNSKepler Trust Intelligence: New Research
21st Jun 20233:07 pmRNSNet Asset Value(s)
20th Jun 20232:51 pmRNSDirector Declaration
20th Jun 202312:00 pmRNSMonthly Investment Report - May 2023
14th Jun 20232:26 pmRNSNet Asset Value(s)
7th Jun 20233:23 pmRNSNet Asset Value(s)
1st Jun 20233:22 pmRNSNet Asset Value(s)
31st May 20235:27 pmRNSTotal Voting Rights
31st May 20232:31 pmRNSNet Asset Value(s)
26th May 20232:28 pmRNSDirector/PDMR Shareholding
24th May 20233:14 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.